toripalimab

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

toripalimab
Jun 6, 2025, 07:49 | Science
Arndt Vogel Highlights HEPATORCH Trial Results Comparing Toripalimab Plus Bevacizumab with Sorafenib in Advanced HCC
Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and…
Jun 1, 2025, 14:52 | Insight
Key Insights by Tom Powles from ASCO25
The ASCO Annual Meeting 2025 is now in full swing in Chicago! From May 30…
May 13, 2025, 16:57 | Insight
Amol Akhade: New ADC plus IO Combo Challenges Frontline HER2+ Metastatic Urothelial Carcinoma Standard
Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, shared a post on LinkedIn:…
May 13, 2025, 08:20 | Insight
Amol Akhade: BREAKING from China - HER2+ Bladder Cancer may have a new contender
Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, posted on X: "BREAKING from China…
Apr 20, 2025, 11:06 | Drugs
Loqtorzi (Toripalimab): What patients need to know?
Toripalimab (Loqtorzi) is a PD-1 inhibitor, a type of immune checkpoint inhibitor that works by…
Apr 19, 2025, 13:12 | Drugs
Toripalimab (Loqtorzi): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Toripalimab is a PD-1 inhibitor, a type of immune checkpoint inhibitor that works by blocking…
Nov 29, 2024, 18:49 | Insight
Dr. Reddy’s has launched Toripalimab in India: Advancing Treatment for Nasopharyngeal Carcinoma
Reddy’s Laboratories Ltd. has announced the launch of Toripalimab, the first and only immuno-oncology drug…
Aug 31, 2024, 12:58 | Insight
Eric Singhi: Our editorial in ASCO Daily News on the CHOICE-01 study
Eric Singhi shared a post on LinkedIn: "It’s always a pleasure to collaborate with my…
Jun 5, 2024, 12:44 | Blog
Tom Powles: Perhaps the most important long-term bladder cancer data at ASCO24
Tom Powles, Director of Barts Cancer Center, shared on X/Twitter: ''Perhaps the most important long-term…
All: 9 Posts: 1 - 100
Special Coverage